Caricamento...
Topical cholesterol/lovastatin for the treatment of porokeratosis: a pathogenesis-directed therapy
BACKGROUND: Porokeratosis is associated with mevalonate pathway gene mutations. Therapeutic options are few and often limited in efficacy. OBJECTIVE: On the basis of preventing the accumulation of toxic metabolites while replenishing essential end-products, we studied the efficacy of topical lovasta...
Salvato in:
| Pubblicato in: | J Am Acad Dermatol |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7039698/ https://ncbi.nlm.nih.gov/pubmed/31449901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaad.2019.08.043 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|